INVESTORS IR Nav Investor Overview Press Releases Events and Presentations Upcoming Events Past Events Presentations Analyst Coverage SEC Filings Stock Information Stock Quote & Chart Historical Price Lookup Investment Calculator Corporate Governance Governance Overview Management Board of Directors Committee Composition Information Request Press Releases Press Releases Year None2020 May 5, 2020 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 2, 2020 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 11, 2020 ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer January 9, 2020 ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics Pagination First page « Previous page ‹ Page 1 Current page 2 Displaying 13 - 16 of 16 IR Tools Print Print Printed Materials Printed Materials Email Alerts Email Alerts RSS Feeds RSS Feeds Email Page Email Page IR Contact Blaine Davis Chief Financial Officer Phone: 646-844-0337 Email: Blaine.Davis@protaratx.com
Press Releases Year None2020 May 5, 2020 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 2, 2020 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 11, 2020 ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer January 9, 2020 ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics Pagination First page « Previous page ‹ Page 1 Current page 2 Displaying 13 - 16 of 16
April 2, 2020 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
